Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 05, 2015 10:22 AM ET

Pharmaceuticals

Company Overview of Reven Pharmaceuticals, Inc.

Company Overview

Reven Pharmaceuticals, Inc., a development-stage healthcare company, focuses on development of products for the treatment of cardiovascular disease and related vascular disorders due to peripheral arterial disease (PAD), diabetes, and other circulatory disorders. Its product in pipeline includes Rejuveinix for the treatment of coronary artery diseases, PAD, endothelial dysfunction, and critical limb ischemia. The company was formerly known as Noventis, Inc. Reven Pharmaceuticals, Inc. was founded in 1999 and is based in Sarasota, Florida.

4411 Bee Ridge Road

Sarasota, FL 34233

United States

Founded in 1999

Phone:

941-320-9271

Key Executives for Reven Pharmaceuticals, Inc.

Chief Executive Officer
President
Vice President of Operations
Vice President
Chief Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
NanoMed Pharmaceuticals, Inc. United States
INO Therapeutics LLC United States
Pennfield Oil Company, Inc. United States
Pentech Pharmaceuticals, Inc. United States
Mills Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Reven Pharmaceuticals, Inc., please visit revenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.